Build a lasting personal brand

Medios AG Closes Aschaffenburg Facility to Strengthen Profitability Amid Margin Pressure

Medios AG is closing its Aschaffenburg manufacturing site and consolidating patient-specific production to improve efficiency and counter sustained margin pressure from price regulatory adjustments.
Medios AG Closes Aschaffenburg Facility to Strengthen Profitability Amid Margin Pressure

Medios AG is closing the facility of its wholly owned subsidiary, Medios Solutions Aschaffenburg GmbH, and consolidating patient-specific manufacturing at its remaining locations in Germany. Production has already been relocated, ensuring uninterrupted supply to pharmacies and hospitals. The Aschaffenburg site accounted for approximately 10% of the Medios Group's German manufacturing production volume. The closure affects 32 employees, for whom Medios is seeking fair compensation.

The decision comes as the business of patient-specific formulations faces sustained margin pressure, particularly due to price regulatory adjustments. Medios is countering this with measures under its Operational Excellence Program to increase efficiency. In Germany, Medios operates a network of six GMP manufacturing facilities for patient-specific therapies. The Aschaffenburg site had been operating at below-average profitability amid declining capacity utilization, making continued economic operation unfeasible. Structural renovation work required at the site accelerated the implementation of this decision.

Thomas Meier, CEO of Medios AG, stated: 'With a view to ensuring a reliable supply for our customers and maintaining capacity utilization at all sites, we are now optimizing our successful regional presence strategy and consistently developing it further. With Mannheim and Stuttgart, we have two high-performing Medios sites in southern Germany, ensuring that a reliable supply is maintained.'

The closure is part of the company's broader Operational Excellence Program, which aims to sustainably strengthen profitability. Medios AG is a leading provider of Specialty Pharma in Europe, with locations in Germany, the Netherlands, Belgium, and Spain. The company supports key partners in the supply chain with innovative solutions and services, focusing on individualized medicine to make innovative therapies available.

Medios AG is Germany's first listed specialty pharmaceutical company, with shares traded on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and included in the SDAX selection index. For more information, visit www.medios.group.

NewsRamp Editorial Team

NewsRamp Editorial Team

@newsramp

From the Pioneers is SEO and AIO News Visibility Newsramp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media. All designed to improve SEO and AIO visibility for your news.